SHP2 inhibitors (Jiangnan University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Jiangsu University of Technology/Nanjing Medical University)

N/A

Report date: 2025/03/20 09:48:08
NME

Base Information

Drug NameSHP2 inhibitors (Jiangnan University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Jiangsu University of Technology/Nanjing Medical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu University of TechnologyNanjing Medical UniversityJiangnan University +[4] 
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A